ASX 100

We investigate the latest lithium market price drivers, as well as ASX lithium stock valuation metrics as lithium prices continue to tumble.

Ten years ago, radiology software company Pro Medicus (ASX:PME) was trading at just 86 cents. Yesterday, with a share price of $149, investors have seen their money...

Suncorp Group CEO Steve Johnston tells us there's plenty of shareholder value on the way.

The Australian consumer has never been more bifurcated, making stock picking a huge challenge. Luckily, we can help you out.

Media is out in force, looking to make its king hit on China’s economy; have they finally got it right? James Cooper doesn’t believe so.

In this episode of Buy Hold Sell, Hayborough's Ben Rundle and Perpetual's Nathan Hughes name the ASX's most skilled leadership teams.

ASX up as dividends surge: CBA, JB Hi-Fi lead payouts. Healthcare sees mixed fortunes, energy stocks fall. Experts break down wild week.

Learn about Goodman Group's latest result in this wire.

Read on to find the ratings, consensus price targets, and FNArena insights on each stock covered.

In this episode, Hayborough's Ben Rundle and Perpetual's Nathan Hughes search for value among some of the ASX's most oversold stocks.

Treasury Wine Estates issued its first full-year result since China removed hefty tariffs on Australian wine imports.

Telstra shares have hit a six-month high on the back of a solid FY24 result and narrowed FY25 guidance.

For macro-minded investors, the CBA earnings chart pack always provides some interesting insights.

The latest Firetrail Equity Edge Podcast has just landed.

We see clear risks going forward and believe it is prudent to price them into valuations.

Iron ore peaked at US$140/t in January but is now closing in on the psychological US$100/t support level. We investigate how low might go.

How could you justify buying a bank that's almost twice as expensive as its peers, with a market cap that's three times its balance sheet.

We take a look at how the members of the Centurion Club (stocks with 1-yr forward P/Es over 100) have performed over the past 12 months.

We still believe QBE Insurance is well-positioned for long-term growth.

The copper price has completely retraced its March-May rally. Major broker Macquarie considers what’s next for Dr Copper.

Australia's biggest healthcare stock disappointed on guidance for FY25, sending its share price south.

Data doesn't always uncover the granular nuances of the economy. That's where company earnings can help.

For background information about this A1-quality company, I previewed REA Group’s (ASX:REA) latest results here, wrote about why I believe REA Group is one of...